WB: Sotorasib superior to docetaxel for treatment of KRASG12C-positive non-small-cell lung cancer
1. Patients allocated to the sotorasib group reported increased progression-free survival compared...
Read More
Imfinzi – Lung Cancer – AZ Imfinzi – Poseidon JUL Display Banners HCP Wallboard Extension- 2023 – 57784
WB: Cemiplimab Plus Chemotherapy Aids QOL in Patients With Lung Cancer
Cemiplimab plus chemotherapy results in significant overall improve- ment in pain symptoms and delayed deterioration in cancer-related and lung cancer-specific symptoms and functions, according to a study published in Cancer....
Read More
WB: Quitting Smoking Early Linked to Lower Mortality After NSCLC Diagnosis
For patients with non-small cell lung cancer (NSCLC), quitting smoking early is associated with...
Read More
WB: “It’s Not About Me”: Coping With Grief and Loss as a Medical Professional
Are healthcare professionals entitled to feel as badly as family members when a patient dies? As I...
Read MoreWB: High-Dose Palliative Radiotherapy for Late-Stage NSCLC Proves Safe & Feasible
For late-stage NSCLC, it is potentially feasible and safe to administer high-dose palliative radiotherapy using 5F or 6F regimes, versus com- parable organs at risk biological equivalent doses (BEDs), according to a study...
Read More